Status:
UNKNOWN
Evaluation of Tumour Growth and Oncological Treatment in Patients With CRLM Using Zebra Fish Embryo Model
Lead Sponsor:
University Hospital, Linkoeping
Collaborating Sponsors:
Medical Research Council of Southeast Sweden
Sahlgrenska University Hospital
Conditions:
Colorectal Cancer Metastatic
Tumour Metastasis
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
In order to improve and individualize cancer treatment, personalized treatment needs to be developed much further. Liver metastasizing colorectal cancer is treated with a combination of oncological an...
Detailed Description
The possibilities to predict oncological tumor response for individual patients with GI malignancies in order to tailor a personalized oncological treatment, are currently limited. This means that mos...
Eligibility Criteria
Inclusion
- Confirmed or suspected diagnosis of colorectal liver metastasis Age 18 years or older ECOG 0-2 Patient can understand verbal and written information -
Exclusion
- Age less than 18 years ECOG \>2 Patient is not able to understand the verbal and written information
- \-
Key Trial Info
Start Date :
May 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 14 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05289076
Start Date
May 17 2022
End Date
March 14 2025
Last Update
December 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Per Sandström
Linköping, Östergötland County, Sweden, 58185